Category: Hepatitis

CATIE HepCinfo Update 6.14

Posted On: Monday, July 27th, 2015

In this issue: CATIE News: Hepatitis C treatment program improves access to housing, income and healthcare HIV/Hep C co-infected people with moderate or severe liver injury at risk for liver-related death People co-infected with Hep C and HIV do less well after liver transplantation

Regional HIV & Hepatitis C Community Action Fund Virtual Roundtable – BC

Posted On: Monday, July 20th, 2015

Wednesday, July 29, 2015 from 9:30-11:00 PDT The Public Health Agency of Canada is continuing its engagement on the Community Action Fund (CAF). An interactive, regional roundtable via webinar is planned for the British Columbia region on Wednesday, July 29, 2015 from 9:30-11:00 PDT. This is a timely opportunity for community organizations to dialogue with the… Read more »

PHCN’s Advocacy Training and Planning Day

Posted On: Monday, July 20th, 2015

PHCN held an Advocacy Training and Planning Day on July 9th in Richmond for hepatitis C advocates from around BC. The Advocacy Training and Planning Day was led by Ryan Clarke of Advocacy Solutions and covered topics from effective advocacy strategies to how to advocate in person and how to effectively tell your own story…. Read more »

CATIE News – Leading Canadian researcher calls for inclusion of co-infected people in large HCV clinical trials

Posted On: Monday, July 20th, 2015

Hepatitis C virus (HCV) infects the liver. Chronic infection with HCV causes inflammation in this vital organ and slowly degrades it as healthy tissue is replaced with scar tissue. This ongoing injury to the liver results in complications, including bacterial infections, internal bleeding and liver, kidney and brain dysfunction. If left untreated, HCV infection can… Read more »

CATIE’s HepCInfo Update 6.13

Posted On: Thursday, July 9th, 2015

New and Noteworthy Holkira Pak added to formulary in Ontario Increasing Hep C treatment could halve Hep C transmission in U.K. gay men over 10 years Statins linked to lower risk of liver failure and death in people with Hep C Holkira Pak added to formulary in Ontario Holkira Pak has been added to the… Read more »

CATIE’s HepCInfo Update 6.12

Posted On: Sunday, June 28th, 2015

New and Noteworthy Daclatasvir receives breakthrough therapy status from the FDA The U.S. Food and Drug Administration (FDA) has granted a breakthrough therapy designation for daclatasvir when used with the already approved medication sofosbuvir (Sovaldi) in people with advanced liver damage. When a medication is designated as a breakthrough therapy the FDA speeds up its… Read more »

World Hepatitis Day 2015

Posted On: Sunday, June 21st, 2015

PAN is compiling a list of World Hepatitis Day events that are taking place around the province. We will share the list of events on the PAN website and in the E-news.   Please submit your event information by Wednesday, July 15th @ 4:00pm.     Please email your event information to Michael Smith, [email protected], with the following… Read more »

Questions and Answers: Prevention of sexually transmitted and blood borne infections among older adults

Posted On: Sunday, June 7th, 2015

The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada is pleased to announce the release of a new resource entitled Questions & Answers: Prevention of sexually transmitted and blood borne infection among older adults. This resource synthesizes research, and highlights promising practices for the prevention of sexually transmitted and blood… Read more »